Surgical intervention
ProcedureSurgical intervention as appropriate for adults with symptomatic lumbar scoliosis
NCT Number: NCT00854828
This is a multicenter study evaluating the effectiveness of nonoperative and operative treatments. The investigators wish to identify important clinical and radiographic determinants of outcomes in the management of adults with symptomatic lumbar scoliosis (ASLS).
Note: Enrollment was complete July 2014. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) funding ended 2/28/17. We continue to follow enrolled subjects while we seek additional funding to follow all subjects through 8 years.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Toronto Western Hospital, Toronto, Ontario, Canada
Specific Aim #1: Compare the outcomes of surgery and nonoperative treatment in patients aged 40 to 80 with ASLS defined as a lumbar curve with a coronal Cobb measurement ≥ 30°, and either of the following: Oswestry (ODI) score of 20 or more; or Scoliosis Research Society Quality of Life instrument (SRS-QOL) score of 4.0 or less, in the domains of pain, function and/or appearance.
Specific Aim #2: Evaluate the impact of patient factors (age, gender, socioeconomic status, education) and comorbidities [mental health, body mass index (BMI) and bone mineral density (BMD)] on adverse events and treatment outcomes for both the nonoperative and operative arms. Incorporate these variables into a prediction model to help identify those patients most likely to benefit from either a surgical or nonoperative approach
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical intervention as appropriate for adults with symptomatic lumbar scoliosis
Non operative intervention as appropriate for treatment of adults with symptomatic lumbar scoliosis such as: injections, medications, physical therapy, etc.
Time frame: Baseline, 2-year
Change was calculated as the SRS QOL Subscore value at 2-year minus the value at Baseline for Randomized Cohort (Intent-to-Treat analysis).
SRS QOL Subscore value range is 1 to 5, where 5 is the best score and 1 is the worst score possible.
Time frame: Baseline, 2-year
Change was calculated as the SRS QOL Subscore value at 2-year as-treated follow-up minus the value at Baseline in the Observational cohort.
SRS QOL Subscore value range is 1 to 5, where 5 is the best score and 1 is the worst score possible.
Time frame: Baseline, 2-year
Change was calculated as the ODI score at 2-year minus the value at Baseline in Randomized Cohort (intent-to-treat analysis).
ODI score range is 0 to 100, where 0 is the best score and 100 is the worst score possible.
Time frame: Baseline, 2-year
Change was calculated as the ODI score at 2-year as treated follow-up minus the value at baseline.
ODI score range is 0 to 100, where 0 is the best score and 100 is the worst score possible.
Washington University School of Medicine
Other
Acronym: ASLS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06416579
Adolescent Idiopathic Scoliosis, Behavior
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06789016
Bone Diseases, Musculoskeletal Diseases
Poznan, Wielkopolska, Poland
View Trial DetailsNCT06828068
Bone Diseases, Musculoskeletal Disease
Hong Kong
View Trial DetailsNCT07470567
Bone Diseases, Musculoskeletal Diseases
Cairo, Katameya Road, Egypt
View Trial Details